Filter News
Area of Research
News Topics
- (-) Coronavirus (29)
- 3-D Printing/Advanced Manufacturing (48)
- Advanced Reactors (17)
- Artificial Intelligence (34)
- Big Data (21)
- Bioenergy (35)
- Biology (34)
- Biomedical (29)
- Biotechnology (8)
- Buildings (15)
- Chemical Sciences (29)
- Clean Water (7)
- Composites (7)
- Computer Science (62)
- Critical Materials (8)
- Cybersecurity (13)
- Education (3)
- Emergency (1)
- Energy Storage (42)
- Environment (72)
- Exascale Computing (18)
- Fossil Energy (2)
- Frontier (20)
- Fusion (22)
- Grid (23)
- High-Performance Computing (36)
- Hydropower (3)
- Irradiation (2)
- Isotopes (19)
- Machine Learning (23)
- Materials (61)
- Materials Science (53)
- Mathematics (4)
- Mercury (3)
- Microelectronics (2)
- Microscopy (15)
- Molten Salt (3)
- Nanotechnology (24)
- National Security (23)
- Neutron Science (67)
- Nuclear Energy (52)
- Partnerships (24)
- Physics (27)
- Polymers (11)
- Quantum Computing (12)
- Quantum Science (23)
- Security (6)
- Simulation (29)
- Software (1)
- Space Exploration (6)
- Summit (26)
- Transportation (33)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 29 Results

Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.

When reading the novel Jurassic Park as a teenager, Jerry Parks found the passages about gene sequencing and supercomputers fascinating, but never imagined he might someday pursue such futuristic-sounding science.

Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.

A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial

A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.

Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.

NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.

To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A collaboration between the ORNL and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.